Skip to content
Sunday, August 30, 2026
LMHPOLITICS · ECONOMIC POLICY
S&P 500−0.35%FTSE 100−0.17%Euro/Dollar+0.22%Brent Crude+1.25%10-Year US+1.40%Markets data →

Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)

Policy Tracker organizes records from Congress.gov API and Federal Register API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records
5,000
Last changed
Update schedule
31 13 * * * UTC
Coverage
04/16/2026–08/31/2026
Method
Methodology
Title
Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
Record Date
07/24/2026
Event Classification
alert
Age Or Deadline Days
37.04
Public Significance Score
62.961